Results 151 to 160 of about 8,261 (192)

T and B cell responses following primary COVID-19 vaccination with CoronaVac and two heterologous BNT162b2 booster doses. [PDF]

mSphere
Wangteeraprasert A, Pongcharoen S, Ngoenkam J, Makanut S.   +3 more
europepmc   +1 more source

Prolonged Evaluation of COVID-19 Vaccine Effectiveness in Healthcare Workers at a Public Tertiary Hospital: A Retrospective Cohort Study. [PDF]

Rev Soc Bras Med Trop
Castro GS, Oliveira YCS, Sawan MMM, Budoia MPP, Soares J, Campos MR, Carvalho FS, Gaspar GG, Fonseca BALD, Colli LM, Pazin-Filho A, Bellissimo-Rodrigues F.   +11 more
europepmc   +1 more source

A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunity. [PDF]

BMC Med
Méndez C, Rodríguez-Guilarte L, Palacios PA, Gutierrez-Vera C, Román F, Moreno-Tapia D, Ríos M, Reyes A, Cancino FA, Otero FF, Zurita C, Rivera D, Cabrera A, Duarte LF, Urzúa M, Iturriaga C, Rojas Á, Perez CM, Redlich AS, Fasce RA, Fernández J, Mora J, Ramírez E, Domínguez A, Weiskopf D, Grifoni A, Sette A, Zeng G, Meng W, Goldbatt D, Johnson M, CoronaVarCL study group, González-Aramundiz JV, Álvarez-Figueroa MJ, Abarca K, Carreño LJ, González PA, Kalergis AM, Peñaloza HF, Bueno SM.   +39 more
europepmc   +1 more source

Single-cell transcriptomics reveals pediatric immune responses to COVID-19 vaccination. [PDF]

iScience
Zhu X, Wang J, Wang X, Feng Z, Wan L, Sun L, Fu J, Xiao F, Huang X, Jia N, Chen M, Zhou J, Wang Y, Wang Q.   +13 more
europepmc   +1 more source

Neutralizing antibody response to different COVID-19 vaccines in Brazil: the impact of previous infection and booster doses. [PDF]

Front Immunol
Caetano BLL, Pinto PBA, Pacheco AR, Lage AR, Pereira ASG, Nascimento AVP, Machado TR, Paulino A, Medeiros TL, Fernandes-Siqueira LO, Da Poian AT, Horbach IS, Azevedo AS, Costa SM, Alves AMB.   +14 more
europepmc   +1 more source

Estimating the Waning Effectiveness of COVID-19 Vaccines From Population-Level Surveillance Data in Hong Kong. [PDF]

J Infect Dis
Chen H, Huang X, Wang C, Cowling BJ, Tsang TK.   +4 more
europepmc   +1 more source

A 20-month longitudinal study to evaluate humoral and cellular immunity after COVID-19 vaccines. [PDF]

Mem Inst Oswaldo Cruz
Sobrinho WBS, Salgado BB, Barbosa ARC, Passos VA, Vieira LP, do Nascimento LD, Lalwani JDB, Lalwani PJ, Nogueira PA.   +8 more
europepmc   +1 more source

Comparative analysis of humoral immunity kinetics following three COVID-19 vaccines in a multi-ethnic cohort of medical students and healthcare professionals across Malaysia. [PDF]

Sci Rep
Thundakattil AV, Prabhu R, Prabhu G, Barman M, Mani M, De S, Lwin H, Giribabu N, Das S.   +8 more
europepmc   +1 more source

Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis. [PDF]

Front Immunol
Biegelmeyer E, de Freitas Aguiar M, Dias Cardoso Ribeiro P, Machado KLLL, Paiva França Telles CM, Euzébio Ribeiro SL, Sarzi Sartori N, Poubel Vieira de Rezende R, Guedes de Melo AK, Alves Cruz V, Rodrigues de Abreu Vieira RM, Kakehasi AM, Dias Corrêa MC, Azevedo VF, Martins-Filho OA, Matos Melo Campos Peixoto FM, de Oliveira Magalhães V, Gomes Gouveia MDP, Karnopp TE, Lino Baptista K, Santos Melo T, Rêgo J, Rodrigues Vieira AS, Faria Moreira Gomes Tavares AC, Dornelas Paz Carvalho V, Peruhype-Magalhães V, Dias LH, Lima de Lima R, da Silva Gonçalves KR, Rodrigues Querido Fortes N, Marques Veghini D, Amorim JA, Tuão RC, Lallemand Tapia KR, Kayser C, Castro CHM, Barbosa Beloni Lirio M, Bühring J, Xavier RM, Teixeira-Carvalho A, Angelina de Souza V, Monticielo OA, Ferreira GA, Pinheiro MM, Torres Dos Reis Neto E, Sato EI, Valim V, Pileggi GS, de Souza AWS.   +48 more
europepmc   +1 more source

Prevalence of herpes zoster in individuals who have received COVID-19 vaccine and/or had COVID-19: a cross-sectional study. [PDF]

BMC Infect Dis
Ispir NG, Pamukcu U, Ispir AH, Peker I, Toraman M.   +4 more
europepmc   +1 more source